Catherine Mazzacco

Insider Reports History

Entity
Individual
Location
C/O Krystal Biotech, Inc., 2100 Wharton Street, Suite 701, Pittsburgh, PA
Signature
/s/ Krish Krishnan, as attorney-in-fact for Catherine Mazzacco
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine Mazzacco:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sight Sciences, Inc. Director Common Stock 47.6K $258K $5.42 Jun 6, 2024 Direct
Krystal Biotech, Inc. Director Stock Option (Right to Buy) 5K Jun 30, 2024 Direct

Insider Reports Filed by Catherine Mazzacco

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KRYS Krystal Biotech, Inc. Jun 30, 2024 1 $0 4 Jul 1, 2024 Director
SGHT Sight Sciences, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
KRYS Krystal Biotech, Inc. Jun 30, 2023 1 $0 4 Jul 3, 2023 Director
SGHT Sight Sciences, Inc. Jun 8, 2023 1 $0 4 Jul 3, 2023 Director
SGHT Sight Sciences, Inc. Jun 8, 2023 0 $0 3 Jul 3, 2023 Director
KRYS Krystal Biotech, Inc. Mar 31, 2023 1 $0 4 Apr 4, 2023 Director
KRYS Krystal Biotech, Inc. Mar 6, 2023 0 $0 3 Mar 9, 2023 Director